No Picture
Boston Cambridge Biotech Trending News

Usher Syndrome Society Commits $500,000 for New Usher Syndrome Research Grants and Forms Scientific Advisory Committee

NEEDHAM, Mass.: NEEDHAM, Mass., Aug. 6, 2021 /PRNewswire/ — The Usher Syndrome Society (USH Society), a non-profit that uses art, educational events, and collaboration to raise awareness and funds for treatments and a cure for […]

No Picture
Boston Cambridge Biotech Trending News

Covid-19 manufacturing roundup: EMA clears 2 New England manufacturing sites for Covid-19 vaccine scale up; Incentives, tax breaks highlight South Korea’s efforts to be vaccine powerhouse 

The EMA has approved a scale-up of production of Moderna’s Covid-19 vaccine Spikevax at two New England sites. If all goes according to plan, the US supply chain will provide 40 million doses of the […]

No Picture
Boston Cambridge Biotech Trending News

PanTher Therapeutics Receives Ethics Approval to Initiate Phase 1 Clinical Trial of PTM-101 in Australia; Announces Appointment of Chief Medical Officer; Establishes Clinical Advisory Board

CAMBRIDGE, Mass.–(BUSINESS WIRE)–PanTher Therapeutics (PanTher), a privately held oncology company revolutionizing the treatment of solid tumors with its proprietary treatment platform designed for direct, localized, and sustained delivery of proven and novel therapeutic agents, announced […]

No Picture
Boston Cambridge Biotech Trending News

SeQure Dx Announces $17.5M Series A Funding

WALTHAM, Mass.–(BUSINESS WIRE)–SeQure Dx, a gene-editing diagnostics company, announced today a $17.5 million Series A funding led by RiverVest Venture Partners and Mass General Brigham Ventures along with Digitalis Ventures, Casdin Capital, KdT Ventures, Bold […]

Boston Cambridge Biotech Trending News

Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021

CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo) today announced that Biogen led a late-breaking presentation on the design of the first real-world observational Phase 4 study […]

No Picture
Boston Cambridge Biotech Trending News

Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference

CAMBRIDGE, Mass.: CAMBRIDGE, Mass., July 7, 2021 /PRNewswire/ — Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will […]

No Picture
Boston Cambridge Biotech Trending News

Exacis Biotherapeutics Makes Strategic Investment In Manufacturing by Hiring Head of Technical Operations and Securing Space in a GMP Cleanroom Facility Recently Completed by Factor Bioscience

CAMBRIDGE, Mass.: CAMBRIDGE, Mass., July 1, 2021 /PRNewswire/ — Exacis Biotherapeutics, Inc., a development-stage immuno-oncology company working to harness the immune system to cure cancer, today announced two significant advances in its manufacturing capabilities. Exacis […]

No Picture
Boston Cambridge Biotech Trending News

ClearB Therapeutics Announces Acceptance of Abstract Highlighting New Pre-Clinical Hepatitis B Data as a Poster Presentation at EASL 2021

CONCORD, Mass. & MELBOURNE, Australia–(BUSINESS WIRE)–ClearB Therapeutics, Inc., a company developing a therapeutic vaccine designed to drive functional cure of hepatitis B, announced today that its abstract entitled ‘A novel therapeutic vaccine achieves functional cure […]